ScreenCell® is proud to participate as an exhibitor and Gold sponsor at the 7th edition of the Advances in Circulating Tumor Cells Meeting (ACTC 2025), taking place from September 24 to 27, 2025, in Thessaloniki, Greece.
This major international event brings together researchers, clinicians, and innovative companies to advance the study of circulating tumor cells (CTCs) and their applications in clinical practice.
During this edition, we will share our vision and latest developments alongside key opinion leaders in the field. We warmly invite all participants to discover—or rediscover—our technology firsthand at our booth (#1).
Throughout the event, our team will be available to help visitors discover and test our circulating tumor cell isolation technology. Visitors will be able to see how easy it is to use and how it can meet their needs.
We will also give a 20-minute oral presentation (date and time to be confirmed) and look forward to discussing with visitors their research projects and specific needs. Whether they are new to our technology or already using it, we will explore how ScreenCell® can support their current and future work.
ACTC 2025 is undoubtedly one of the must-attend events for staying at the forefront of advances in circulating tumor cells. Don’t hesitate to visit the official conference website (www.actc2025.org) to find out about registration details and available fees.
